DEXP4 Stock Overview
Engages in the production and sale of thermosetting resins to the reconstituted wood panels industry in Brazil.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Dexxos Participações S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$10.28 |
| 52 Week High | R$13.45 |
| 52 Week Low | R$8.42 |
| Beta | 1.04 |
| 11 Month Change | -0.19% |
| 3 Month Change | -4.81% |
| 1 Year Change | 11.74% |
| 33 Year Change | -19.90% |
| 5 Year Change | n/a |
| Change since IPO | 23.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| DEXP4 | BR Chemicals | BR Market | |
|---|---|---|---|
| 7D | 3.8% | 1.1% | 1.9% |
| 1Y | 11.7% | -29.6% | -1.4% |
Return vs Industry: DEXP4 exceeded the BR Chemicals industry which returned -29.6% over the past year.
Return vs Market: DEXP4 exceeded the BR Market which returned -1.4% over the past year.
Price Volatility
| DEXP4 volatility | |
|---|---|
| DEXP4 Average Weekly Movement | 5.7% |
| Chemicals Industry Average Movement | 4.9% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 9.1% |
| 10% least volatile stocks in BR Market | 2.2% |
Stable Share Price: DEXP4 has not had significant price volatility in the past 3 months.
Volatility Over Time: DEXP4's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1929 | n/a | Rafael Raphael | www.dexxos.com.br |
Dexxos Participações S.A. engages in the production and sale of thermosetting resins to the reconstituted wood panels industry in Brazil. The company also engages in the production of formaldehyde; and resale of methanol and other chemical products. In addition, it manufactures tubes for construction, infrastructure, and automobile markets; and produces steel tubes for oil and gas segment.
Dexxos Participações S.A. Fundamentals Summary
| DEXP4 fundamental statistics | |
|---|---|
| Market cap | R$964.58m |
| Earnings (TTM) | R$175.60m |
| Revenue (TTM) | R$1.66b |
5.5x
P/E Ratio0.6x
P/S RatioIs DEXP4 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DEXP4 income statement (TTM) | |
|---|---|
| Revenue | R$1.66b |
| Cost of Revenue | R$1.33b |
| Gross Profit | R$330.88m |
| Other Expenses | R$155.29m |
| Earnings | R$175.60m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.88 |
| Gross Margin | 19.88% |
| Net Profit Margin | 10.55% |
| Debt/Equity Ratio | 29.5% |
How did DEXP4 perform over the long term?
See historical performance and comparison